[1] Wagner FF,Flegel WA. Review:the molecular basis of the Rh
blood group phenotypes.Immunohematology,2004,20:23-36.
[2] 邵超鹏,尚桂芳,聚合酶链式反应技术检测Rh血型Del表型[J]临床检验杂志,2004,22(1):12.
[3] Wagner FF,Gassner C,Muller TH,et a1.Molecular basis of weak
D phenotypes.Blood,1999;93:385—393.
[4] Legler TJ,Maas JH ,Kohler M ,et a1. RHD sequencing:a new tool for decision making on transfusion therapy and provision of Rh
prophylaxis. Transfus Med,2001;11:383—388.
[5] Beckers EA,Faas BH,Ligthart P,et a1.Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene Transfusion,1997,37(6):616.
[6] Rouillac C,Gane P,Cartron J,et a1.Molecular basis of the altered antigenic expression of RhD in weak D(Du)and RhC/e in RH phenotypes.Blood,1996,87(11):4853.
[7] Flegel WA ,Wangner FF.Molecular genetics of RH[J].Vox Sang,2000;78(suppl2):109-115.
[8] Wagner FF,Frohmajer A,Flegel W A.RHD positive haplotypes in D negative Europeans[J].BMC Genet,2001,2(1):1O-18.
[9] Cowley NM ,Saul A,Hyland CA,et a1.RHD gene mutation and weak D phenotype:an Australian blood donor study[J].Vox Sang 2000,79(4):251-252.
[10] 吴俊杰, 洪小珍,许先国,傅启华,严力行.RHD基因测序方法的建立及其在弱D表型分子鉴定中的应用.中华检验医学杂志.2006;29(5):460-462.